4
Total investments
1
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2019
Were championing possibilities for all by making money fast, easy, and more enjoyable. Our hope is to unlock opportunities for people in their everyday lives and empower the millions of people and businesses around the world who trust, rely, and use PayPal every day.
For support, visit the PayPal Help Center. https://payp.al/help
For employment opportunities, check out our job openings in the Jobs tab. Were an equal opportunity employer that welcomes diversity, and offer generous benefits to help you thrive at work and in your free time.
NMLS#910457: https://nmlsconsumeraccess.org/
Board Member
Oct 2018
The Idea-to-Production Platform
Rapidly design, develop and scale production of better products in less time with the Carbon platform. Integrated end-use materials, software, and 3D printers enable teams to accelerate bringing products to market — from idea to production.
Create radically better products with Carbon.
Board Member
Sep 2018
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.
For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines
Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.
Experience · 5 entries
All (5)
Investments (4)
Board (4)
2022
Board Member
Jan 2022
TPG (Nasdaq: TPG) is a leading global alternative asset management firm, founded in San Francisco in 1992, with $306 billion of assets under management and investment and operational teams around the world. TPG invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, and market solutions, and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities. For more information, visit www.tpg.com.
---
Disclaimer: The information on this page is for informational purposes only. Nothing on or within this page constitutes an offer to sell, or a solicitation of an offer to buy, any security or product of TPG or any TPG-managed fund. TPG is not responsible for any content posted by third parties on these pages.
2019
Board Member
Jan 2019
Were championing possibilities for all by making money fast, easy, and more enjoyable. Our hope is to unlock opportunities for people in their everyday lives and empower the millions of people and businesses around the world who trust, rely, and use PayPal every day.
For support, visit the PayPal Help Center. https://payp.al/help
For employment opportunities, check out our job openings in the Jobs tab. Were an equal opportunity employer that welcomes diversity, and offer generous benefits to help you thrive at work and in your free time.
NMLS#910457: https://nmlsconsumeraccess.org/
2018
Board Member
Oct 2018
The Idea-to-Production Platform
Rapidly design, develop and scale production of better products in less time with the Carbon platform. Integrated end-use materials, software, and 3D printers enable teams to accelerate bringing products to market — from idea to production.
Create radically better products with Carbon.
Board Member
Sep 2018
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.
For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines
Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers.
1982
Managing Partner, Bay Area and Northwest Market
1982
KPMG is a global organization of independent professional services firms providing Audit, Tax and Advisory services. KPMG is the brand under which the member firms of KPMG International Limited (“KPMG International”) operate and provide professional services. “KPMG” is used to refer to individual member firms within the KPMG organization or to one or more member firms collectively.
KPMG firms operate in 143 countries and territories with more than 273,000 partners and employees working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such. Each KPMG member firm is responsible for its own obligations and liabilities.
KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients.
For more detail about our structure, please visit kpmg.com/governance.
Investment activity
2018–2022 · 4 investments
Recent (last 2 years)Earlier
